千红制药 (002550.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(千红制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 53.0045.0046.0045.0039.0037.0042.0036.0040.00
 单季度销售净利率(%) 22.00-3.0018.007.0014.0010.0012.0012.0023.00
 单季度净资产收益率ROE(%) 4.00-1.003.001.003.002.003.003.006.00
 单季度总资产净利率ROA(%) 4.00-3.001.003.002.002.003.005.00
单季度财务摘要:
 单季度营业总收入(元) 461,101,488.00348,327,598.00409,185,174.00448,537,232.00608,218,905.00654,718,749.00511,943,232.00584,665,276.00552,220,534.00
 单季度营业总成本(元) 344,356,267.00365,585,337.00363,829,473.00419,405,867.00517,224,548.00598,957,152.00447,963,671.00493,177,759.00451,115,340.00
 单季度营业收入(元) 461,101,488.00348,327,598.00409,185,174.00448,537,232.00608,218,905.00654,718,749.00511,943,232.00584,665,276.00552,220,534.00
 单季度营业利润(元) 117,007,469.0010,017,082.0059,656,143.0032,450,916.00102,232,382.00116,546,440.0067,631,473.0082,012,158.0093,816,402.00
 单季度利润总额(元) 116,834,899.00-15,252,840.0084,016,300.0032,403,786.00102,356,234.0058,368,952.0067,851,968.0082,305,593.00151,803,912.00
 单季度净利润(元) 101,346,704.00-8,980,285.0073,982,341.0030,120,155.0083,549,828.0062,712,638.0061,452,178.0069,949,883.00125,796,128.00
 单季度归属母公司股东的净利润(元) 104,108,160.00-15,994,360.0078,829,270.0033,078,989.0085,946,848.0055,016,029.0066,541,578.0073,609,254.00128,247,521.00
 单季度经营活动产生的现金流量(元) 171,109,915.00142,325,723.00283,617,402.00135,465,186.00-28,080,311.00-16,713,687.00-35,040,389.00-111,692,824.0091,973,049.00
 单季度投资活动产生的现金流量(元) 81,085,342.00-67,057,244.00-5,824,234.005,245,622.00-107,460,997.00-28,107,900.00-183,284,820.0015,447,840.005,965,581.00
 单季度筹资活动产生的现金流量(元) -140,967,340.0035,437,444.00-239,788,966.00-185,602,483.00199,080,789.00-45,958,236.00116,998,824.00-165,734,536.00105,710,815.00
 单季度现金及现金等价物净增加(元) 109,228,402.00110,328,147.0039,522,015.00-45,298,034.0061,209,681.00-99,598,560.00-88,331,131.00-221,993,484.00201,373,916.00

前瞻产业研究院